Sherpa Ventures Fund, LP 3
3 · Cue Health Inc. · Filed Sep 23, 2021
Insider Transaction Report
Form 3
Cue Health Inc.HLTH
Sherpa Ventures Fund, LP
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (3,834,088 underlying)Series C-1 Preferred Stock
→ Common Stock (1,092,329 underlying)- 194,031
Common Stock
- 129,354
Common Stock
Series A Preferred Stock
→ Common Stock (5,450,898 underlying)Series B Preferred Stock
→ Common Stock (3,076,224 underlying)Series C-1 Preferred Stock
→ Common Stock (1,092,329 underlying)
Footnotes (5)
- [F1]The shares are held directly by Sherpa Ventures Fund, LP ("ACME I"). Sherpa Ventures Fund GP, LLC ("ACME GP I") is the general partner of ACME I. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II (as defined below) and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II (as defined below) and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
- [F2]The shares are held directly by Sherpa Ventures Fund II, LP ("ACME II"). Sherpa Ventures Fund II GP, LLC ("ACME GP II") is the general partner of ACME II. Scott Stanford is the sole managing member of each of ACME GP I and ACME GP II and may be deemed to have voting and investment power with respect to the shares held by ACME I and ACME II and as a result may be deemed to have beneficial ownership of such shares. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of his or its respective pecuniary interest therein.
- [F3]The Series A Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F4]The Series B Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.
- [F5]The Series C-1 Preferred Stock automatically converts into the number of shares of Common Stock as shown in Column 3 of Table II without payment of further consideration at the holder's election or upon closing of the initial public offering of the Issuer's common stock. The shares have no expiration date.